Industry Research Reports
Global Astragaloside IV Market Insights, Forecast to 2030
Industry: Chemical & Material
Published Date: 2024-04-07
Pages: 96 Pages
Report ld: 2816800
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Astragaloside IV Market Size(US$)
CAGR 2024-2030
3.3%
Market Size,2030
USD 90
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 74 million
Market Forecast in 2030(Value)
US$ 90 million
CAGR
3.3%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Astragaloside IV extract from astragalus Root.
The global Astragaloside IV market is projected to grow from US$ 74 million in 2024 to US$ 90 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.3% during the forecast period.
Plant extracts are substances or active substances with desired properties extracted from plant tissue and processed for a specific purpose. It is used in various fields, such as health foods, therapeutic drugs, cosmetics, processing aids, additives chemical substitutes. The market’s growth is driven by lifestyle changes, consumer awareness, increasing use of products based on natural ingredients, and biotechnology breakthroughs. Additionally, macroeconomic variables such as rising consumer disposable income, research and development, imports and exports, growth in the agriculture industry, population aging, and population growth have positively impacted the demand for plant extracts in recent years. It is also becoming increasingly popular in cosmetics, perfumes, pharmaceuticals, and dietary supplements. The plant extracts market was valued at USD 31.84 billion in 2022 and is expected to grow at a CAGR of 11.3% during the forecast period.
In terms of production side, this report researches the Astragaloside IV production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Astragaloside IV by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Astragaloside IV, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Astragaloside IV, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Astragaloside IV, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Astragaloside IV sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Astragaloside IV market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Astragaloside IV sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
By Company
- NandR Bio Industries
- Zenergy Korea Corporation
- Bio-norm
- Wuhan Vanz Pharm
- Shaanxi Pioneer Biotech
- Xi'an Lyphar Biotech
- Xian Pincredit Bio-Tech
- Shaanxi Fuheng (FH) Biotechnology
- Nanjing NutriHerb BioTech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 0.1
- 0.98
- Others
Segment by Application
- Food Industry
- Pharmaceuticals Industry
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Astragaloside IV production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Astragaloside IV in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Astragaloside IV manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Astragaloside IV sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Astragaloside IV Product Introduction
1.2 Market by Type
1.2.1 Global Astragaloside IV Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 0.1
1.2.3 0.98
1.2.4 Others
1.3 Market by Application
1.3.1 Global Astragaloside IV Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Food Industry
1.3.3 Pharmaceuticals Industry
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Astragaloside IV Production
2.1 Global Astragaloside IV Production Capacity (2019-2030)
2.2 Global Astragaloside IV Production by Region: 2019 VS 2023 VS 2030
2.3 Global Astragaloside IV Production by Region
2.3.1 Global Astragaloside IV Historic Production by Region (2019-2024)
2.3.2 Global Astragaloside IV Forecasted Production by Region (2025-2030)
2.3.3 Global Astragaloside IV Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Astragaloside IV Revenue Estimates and Forecasts 2019-2030
3.2 Global Astragaloside IV Revenue by Region
3.2.1 Global Astragaloside IV Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Astragaloside IV Revenue by Region (2019-2024)
3.2.3 Global Astragaloside IV Revenue by Region (2025-2030)
3.2.4 Global Astragaloside IV Revenue Market Share by Region (2019-2030)
3.3 Global Astragaloside IV Sales Estimates and Forecasts 2019-2030
3.4 Global Astragaloside IV Sales by Region
3.4.1 Global Astragaloside IV Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Astragaloside IV Sales by Region (2019-2024)
3.4.3 Global Astragaloside IV Sales by Region (2025-2030)
3.4.4 Global Astragaloside IV Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Astragaloside IV Sales by Manufacturers
4.1.1 Global Astragaloside IV Sales by Manufacturers (2019-2024)
4.1.2 Global Astragaloside IV Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Astragaloside IV in 2023
4.2 Global Astragaloside IV Revenue by Manufacturers
4.2.1 Global Astragaloside IV Revenue by Manufacturers (2019-2024)
4.2.2 Global Astragaloside IV Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Astragaloside IV Revenue in 2023
4.3 Global Astragaloside IV Sales Price by Manufacturers
4.4 Global Key Players of Astragaloside IV, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Astragaloside IV Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Astragaloside IV, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Astragaloside IV, Product Offered and Application
4.8 Global Key Manufacturers of Astragaloside IV, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Astragaloside IV Sales by Type
5.1.1 Global Astragaloside IV Historical Sales by Type (2019-2024)
5.1.2 Global Astragaloside IV Forecasted Sales by Type (2025-2030)
5.1.3 Global Astragaloside IV Sales Market Share by Type (2019-2030)
5.2 Global Astragaloside IV Revenue by Type
5.2.1 Global Astragaloside IV Historical Revenue by Type (2019-2024)
5.2.2 Global Astragaloside IV Forecasted Revenue by Type (2025-2030)
5.2.3 Global Astragaloside IV Revenue Market Share by Type (2019-2030)
5.3 Global Astragaloside IV Price by Type
5.3.1 Global Astragaloside IV Price by Type (2019-2024)
5.3.2 Global Astragaloside IV Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Astragaloside IV Sales by Application
6.1.1 Global Astragaloside IV Historical Sales by Application (2019-2024)
6.1.2 Global Astragaloside IV Forecasted Sales by Application (2025-2030)
6.1.3 Global Astragaloside IV Sales Market Share by Application (2019-2030)
6.2 Global Astragaloside IV Revenue by Application
6.2.1 Global Astragaloside IV Historical Revenue by Application (2019-2024)
6.2.2 Global Astragaloside IV Forecasted Revenue by Application (2025-2030)
6.2.3 Global Astragaloside IV Revenue Market Share by Application (2019-2030)
6.3 Global Astragaloside IV Price by Application
6.3.1 Global Astragaloside IV Price by Application (2019-2024)
6.3.2 Global Astragaloside IV Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Astragaloside IV Market Size by Type
7.1.1 US & Canada Astragaloside IV Sales by Type (2019-2030)
7.1.2 US & Canada Astragaloside IV Revenue by Type (2019-2030)
7.2 US & Canada Astragaloside IV Market Size by Application
7.2.1 US & Canada Astragaloside IV Sales by Application (2019-2030)
7.2.2 US & Canada Astragaloside IV Revenue by Application (2019-2030)
7.3 US & Canada Astragaloside IV Sales by Country
7.3.1 US & Canada Astragaloside IV Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Astragaloside IV Sales by Country (2019-2030)
7.3.3 US & Canada Astragaloside IV Revenue by Country (2019-2030)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Astragaloside IV Market Size by Type
8.1.1 Europe Astragaloside IV Sales by Type (2019-2030)
8.1.2 Europe Astragaloside IV Revenue by Type (2019-2030)
8.2 Europe Astragaloside IV Market Size by Application
8.2.1 Europe Astragaloside IV Sales by Application (2019-2030)
8.2.2 Europe Astragaloside IV Revenue by Application (2019-2030)
8.3 Europe Astragaloside IV Sales by Country
8.3.1 Europe Astragaloside IV Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Astragaloside IV Sales by Country (2019-2030)
8.3.3 Europe Astragaloside IV Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Astragaloside IV Market Size by Type
9.1.1 China Astragaloside IV Sales by Type (2019-2030)
9.1.2 China Astragaloside IV Revenue by Type (2019-2030)
9.2 China Astragaloside IV Market Size by Application
9.2.1 China Astragaloside IV Sales by Application (2019-2030)
9.2.2 China Astragaloside IV Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Astragaloside IV Market Size by Type
10.1.1 Asia Astragaloside IV Sales by Type (2019-2030)
10.1.2 Asia Astragaloside IV Revenue by Type (2019-2030)
10.2 Asia Astragaloside IV Market Size by Application
10.2.1 Asia Astragaloside IV Sales by Application (2019-2030)
10.2.2 Asia Astragaloside IV Revenue by Application (2019-2030)
10.3 Asia Astragaloside IV Sales by Region
10.3.1 Asia Astragaloside IV Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Astragaloside IV Revenue by Region (2019-2030)
10.3.3 Asia Astragaloside IV Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Astragaloside IV Market Size by Type
11.1.1 Middle East, Africa and Latin America Astragaloside IV Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Astragaloside IV Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Astragaloside IV Market Size by Application
11.2.1 Middle East, Africa and Latin America Astragaloside IV Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Astragaloside IV Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Astragaloside IV Sales by Country
11.3.1 Middle East, Africa and Latin America Astragaloside IV Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Astragaloside IV Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Astragaloside IV Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 NandR Bio Industries
12.1.1 NandR Bio Industries Company Information
12.1.2 NandR Bio Industries Overview
12.1.3 NandR Bio Industries Astragaloside IV Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 NandR Bio Industries Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 NandR Bio Industries Recent Developments
12.2 Zenergy Korea Corporation
12.2.1 Zenergy Korea Corporation Company Information
12.2.2 Zenergy Korea Corporation Overview
12.2.3 Zenergy Korea Corporation Astragaloside IV Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Zenergy Korea Corporation Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Zenergy Korea Corporation Recent Developments
12.3 Bio-norm
12.3.1 Bio-norm Company Information
12.3.2 Bio-norm Overview
12.3.3 Bio-norm Astragaloside IV Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Bio-norm Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Bio-norm Recent Developments
12.4 Wuhan Vanz Pharm
12.4.1 Wuhan Vanz Pharm Company Information
12.4.2 Wuhan Vanz Pharm Overview
12.4.3 Wuhan Vanz Pharm Astragaloside IV Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Wuhan Vanz Pharm Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Wuhan Vanz Pharm Recent Developments
12.5 Shaanxi Pioneer Biotech
12.5.1 Shaanxi Pioneer Biotech Company Information
12.5.2 Shaanxi Pioneer Biotech Overview
12.5.3 Shaanxi Pioneer Biotech Astragaloside IV Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 Shaanxi Pioneer Biotech Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Shaanxi Pioneer Biotech Recent Developments
12.6 Xi'an Lyphar Biotech
12.6.1 Xi'an Lyphar Biotech Company Information
12.6.2 Xi'an Lyphar Biotech Overview
12.6.3 Xi'an Lyphar Biotech Astragaloside IV Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 Xi'an Lyphar Biotech Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Xi'an Lyphar Biotech Recent Developments
12.7 Xian Pincredit Bio-Tech
12.7.1 Xian Pincredit Bio-Tech Company Information
12.7.2 Xian Pincredit Bio-Tech Overview
12.7.3 Xian Pincredit Bio-Tech Astragaloside IV Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.7.4 Xian Pincredit Bio-Tech Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Xian Pincredit Bio-Tech Recent Developments
12.8 Shaanxi Fuheng (FH) Biotechnology
12.8.1 Shaanxi Fuheng (FH) Biotechnology Company Information
12.8.2 Shaanxi Fuheng (FH) Biotechnology Overview
12.8.3 Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.8.4 Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Shaanxi Fuheng (FH) Biotechnology Recent Developments
12.9 Nanjing NutriHerb BioTech
12.9.1 Nanjing NutriHerb BioTech Company Information
12.9.2 Nanjing NutriHerb BioTech Overview
12.9.3 Nanjing NutriHerb BioTech Astragaloside IV Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.9.4 Nanjing NutriHerb BioTech Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Nanjing NutriHerb BioTech Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Astragaloside IV Industry Chain Analysis
13.2 Astragaloside IV Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Astragaloside IV Production Mode & Process
13.4 Astragaloside IV Sales and Marketing
13.4.1 Astragaloside IV Sales Channels
13.4.2 Astragaloside IV Distributors
13.5 Astragaloside IV Customers
14 Astragaloside IV Market Dynamics
14.1 Astragaloside IV Industry Trends
14.2 Astragaloside IV Market Drivers
14.3 Astragaloside IV Market Challenges
14.4 Astragaloside IV Market Restraints
15 Key Finding in The Global Astragaloside IV Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Astragaloside IV Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of 0.1
Table 3. Major Manufacturers of 0.98
Table 4. Major Manufacturers of Others
Table 5. Global Astragaloside IV Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Astragaloside IV Production by Region: 2019 VS 2023 VS 2030 (MT)
Table 7. Global Astragaloside IV Production by Region (2019-2024) & (MT)
Table 8. Global Astragaloside IV Production by Region (2025-2030) & (MT)
Table 9. Global Astragaloside IV Production Market Share by Region (2019-2024)
Table 10. Global Astragaloside IV Production Market Share by Region (2025-2030)
Table 11. Global Astragaloside IV Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Astragaloside IV Revenue by Region (2019-2024) & (US$ Million)
Table 13. Global Astragaloside IV Revenue by Region (2025-2030) & (US$ Million)
Table 14. Global Astragaloside IV Revenue Market Share by Region (2019-2024)
Table 15. Global Astragaloside IV Revenue Market Share by Region (2025-2030)
Table 16. Global Astragaloside IV Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Astragaloside IV Sales by Region (2019-2024) & (MT)
Table 18. Global Astragaloside IV Sales by Region (2025-2030) & (MT)
Table 19. Global Astragaloside IV Sales Market Share by Region (2019-2024)
Table 20. Global Astragaloside IV Sales Market Share by Region (2025-2030)
Table 21. Global Astragaloside IV Sales by Manufacturers (2019-2024) & (MT)
Table 22. Global Astragaloside IV Sales Share by Manufacturers (2019-2024)
Table 23. Global Astragaloside IV Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 24. Global Astragaloside IV Revenue Share by Manufacturers (2019-2024)
Table 25. Astragaloside IV Price by Manufacturers 2019-2024 (USD/Kg)
Table 26. Global Key Players of Astragaloside IV, Industry Ranking, 2022 VS 2023 VS 2024
Table 27. Global Astragaloside IV Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Astragaloside IV by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Astragaloside IV as of 2023)
Table 29. Global Key Manufacturers of Astragaloside IV, Manufacturing Base Distribution and Headquarters
Table 30. Global Key Manufacturers of Astragaloside IV, Product Offered and Application
Table 31. Global Key Manufacturers of Astragaloside IV, Date of Enter into This Industry
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Astragaloside IV Sales by Type (2019-2024) & (MT)
Table 34. Global Astragaloside IV Sales by Type (2025-2030) & (MT)
Table 35. Global Astragaloside IV Sales Share by Type (2019-2024)
Table 36. Global Astragaloside IV Sales Share by Type (2025-2030)
Table 37. Global Astragaloside IV Revenue by Type (2019-2024) & (US$ Million)
Table 38. Global Astragaloside IV Revenue by Type (2025-2030) & (US$ Million)
Table 39. Global Astragaloside IV Revenue Share by Type (2019-2024)
Table 40. Global Astragaloside IV Revenue Share by Type (2025-2030)
Table 41. Astragaloside IV Price by Type (2019-2024) & (USD/Kg)
Table 42. Global Astragaloside IV Price Forecast by Type (2025-2030) & (USD/Kg)
Table 43. Global Astragaloside IV Sales by Application (2019-2024) & (MT)
Table 44. Global Astragaloside IV Sales by Application (2025-2030) & (MT)
Table 45. Global Astragaloside IV Sales Share by Application (2019-2024)
Table 46. Global Astragaloside IV Sales Share by Application (2025-2030)
Table 47. Global Astragaloside IV Revenue by Application (2019-2024) & (US$ Million)
Table 48. Global Astragaloside IV Revenue by Application (2025-2030) & (US$ Million)
Table 49. Global Astragaloside IV Revenue Share by Application (2019-2024)
Table 50. Global Astragaloside IV Revenue Share by Application (2025-2030)
Table 51. Astragaloside IV Price by Application (2019-2024) & (USD/Kg)
Table 52. Global Astragaloside IV Price Forecast by Application (2025-2030) & (USD/Kg)
Table 53. US & Canada Astragaloside IV Sales by Type (2019-2024) & (MT)
Table 54. US & Canada Astragaloside IV Sales by Type (2025-2030) & (MT)
Table 55. US & Canada Astragaloside IV Revenue by Type (2019-2024) & (US$ Million)
Table 56. US & Canada Astragaloside IV Revenue by Type (2025-2030) & (US$ Million)
Table 57. US & Canada Astragaloside IV Sales by Application (2019-2024) & (MT)
Table 58. US & Canada Astragaloside IV Sales by Application (2025-2030) & (MT)
Table 59. US & Canada Astragaloside IV Revenue by Application (2019-2024) & (US$ Million)
Table 60. US & Canada Astragaloside IV Revenue by Application (2025-2030) & (US$ Million)
Table 61. US & Canada Astragaloside IV Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 62. US & Canada Astragaloside IV Revenue by Country (2019-2024) & (US$ Million)
Table 63. US & Canada Astragaloside IV Revenue by Country (2025-2030) & (US$ Million)
Table 64. US & Canada Astragaloside IV Sales by Country (2019-2024) & (MT)
Table 65. US & Canada Astragaloside IV Sales by Country (2025-2030) & (MT)
Table 66. Europe Astragaloside IV Sales by Type (2019-2024) & (MT)
Table 67. Europe Astragaloside IV Sales by Type (2025-2030) & (MT)
Table 68. Europe Astragaloside IV Revenue by Type (2019-2024) & (US$ Million)
Table 69. Europe Astragaloside IV Revenue by Type (2025-2030) & (US$ Million)
Table 70. Europe Astragaloside IV Sales by Application (2019-2024) & (MT)
Table 71. Europe Astragaloside IV Sales by Application (2025-2030) & (MT)
Table 72. Europe Astragaloside IV Revenue by Application (2019-2024) & (US$ Million)
Table 73. Europe Astragaloside IV Revenue by Application (2025-2030) & (US$ Million)
Table 74. Europe Astragaloside IV Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 75. Europe Astragaloside IV Revenue by Country (2019-2024) & (US$ Million)
Table 76. Europe Astragaloside IV Revenue by Country (2025-2030) & (US$ Million)
Table 77. Europe Astragaloside IV Sales by Country (2019-2024) & (MT)
Table 78. Europe Astragaloside IV Sales by Country (2025-2030) & (MT)
Table 79. China Astragaloside IV Sales by Type (2019-2024) & (MT)
Table 80. China Astragaloside IV Sales by Type (2025-2030) & (MT)
Table 81. China Astragaloside IV Revenue by Type (2019-2024) & (US$ Million)
Table 82. China Astragaloside IV Revenue by Type (2025-2030) & (US$ Million)
Table 83. China Astragaloside IV Sales by Application (2019-2024) & (MT)
Table 84. China Astragaloside IV Sales by Application (2025-2030) & (MT)
Table 85. China Astragaloside IV Revenue by Application (2019-2024) & (US$ Million)
Table 86. China Astragaloside IV Revenue by Application (2025-2030) & (US$ Million)
Table 87. Asia Astragaloside IV Sales by Type (2019-2024) & (MT)
Table 88. Asia Astragaloside IV Sales by Type (2025-2030) & (MT)
Table 89. Asia Astragaloside IV Revenue by Type (2019-2024) & (US$ Million)
Table 90. Asia Astragaloside IV Revenue by Type (2025-2030) & (US$ Million)
Table 91. Asia Astragaloside IV Sales by Application (2019-2024) & (MT)
Table 92. Asia Astragaloside IV Sales by Application (2025-2030) & (MT)
Table 93. Asia Astragaloside IV Revenue by Application (2019-2024) & (US$ Million)
Table 94. Asia Astragaloside IV Revenue by Application (2025-2030) & (US$ Million)
Table 95. Asia Astragaloside IV Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 96. Asia Astragaloside IV Revenue by Region (2019-2024) & (US$ Million)
Table 97. Asia Astragaloside IV Revenue by Region (2025-2030) & (US$ Million)
Table 98. Asia Astragaloside IV Sales by Region (2019-2024) & (MT)
Table 99. Asia Astragaloside IV Sales by Region (2025-2030) & (MT)
Table 100. Middle East, Africa and Latin America Astragaloside IV Sales by Type (2019-2024) & (MT)
Table 101. Middle East, Africa and Latin America Astragaloside IV Sales by Type (2025-2030) & (MT)
Table 102. Middle East, Africa and Latin America Astragaloside IV Revenue by Type (2019-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Astragaloside IV Revenue by Type (2025-2030) & (US$ Million)
Table 104. Middle East, Africa and Latin America Astragaloside IV Sales by Application (2019-2024) & (MT)
Table 105. Middle East, Africa and Latin America Astragaloside IV Sales by Application (2025-2030) & (MT)
Table 106. Middle East, Africa and Latin America Astragaloside IV Revenue by Application (2019-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Astragaloside IV Revenue by Application (2025-2030) & (US$ Million)
Table 108. Middle East, Africa and Latin America Astragaloside IV Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 109. Middle East, Africa and Latin America Astragaloside IV Revenue by Country (2019-2024) & (US$ Million)
Table 110. Middle East, Africa and Latin America Astragaloside IV Revenue by Country (2025-2030) & (US$ Million)
Table 111. Middle East, Africa and Latin America Astragaloside IV Sales by Country (2019-2024) & (MT)
Table 112. Middle East, Africa and Latin America Astragaloside IV Sales by Country (2025-2030) & (MT)
Table 113. NandR Bio Industries Company Information
Table 114. NandR Bio Industries Description and Major Businesses
Table 115. NandR Bio Industries Astragaloside IV Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 116. NandR Bio Industries Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. NandR Bio Industries Recent Development
Table 118. Zenergy Korea Corporation Company Information
Table 119. Zenergy Korea Corporation Description and Major Businesses
Table 120. Zenergy Korea Corporation Astragaloside IV Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 121. Zenergy Korea Corporation Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Zenergy Korea Corporation Recent Development
Table 123. Bio-norm Company Information
Table 124. Bio-norm Description and Major Businesses
Table 125. Bio-norm Astragaloside IV Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 126. Bio-norm Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Bio-norm Recent Development
Table 128. Wuhan Vanz Pharm Company Information
Table 129. Wuhan Vanz Pharm Description and Major Businesses
Table 130. Wuhan Vanz Pharm Astragaloside IV Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 131. Wuhan Vanz Pharm Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Wuhan Vanz Pharm Recent Development
Table 133. Shaanxi Pioneer Biotech Company Information
Table 134. Shaanxi Pioneer Biotech Description and Major Businesses
Table 135. Shaanxi Pioneer Biotech Astragaloside IV Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 136. Shaanxi Pioneer Biotech Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Shaanxi Pioneer Biotech Recent Development
Table 138. Xi'an Lyphar Biotech Company Information
Table 139. Xi'an Lyphar Biotech Description and Major Businesses
Table 140. Xi'an Lyphar Biotech Astragaloside IV Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 141. Xi'an Lyphar Biotech Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Xi'an Lyphar Biotech Recent Development
Table 143. Xian Pincredit Bio-Tech Company Information
Table 144. Xian Pincredit Bio-Tech Description and Major Businesses
Table 145. Xian Pincredit Bio-Tech Astragaloside IV Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 146. Xian Pincredit Bio-Tech Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Xian Pincredit Bio-Tech Recent Development
Table 148. Shaanxi Fuheng (FH) Biotechnology Company Information
Table 149. Shaanxi Fuheng (FH) Biotechnology Description and Major Businesses
Table 150. Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 151. Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Shaanxi Fuheng (FH) Biotechnology Recent Development
Table 153. Nanjing NutriHerb BioTech Company Information
Table 154. Nanjing NutriHerb BioTech Description and Major Businesses
Table 155. Nanjing NutriHerb BioTech Astragaloside IV Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 156. Nanjing NutriHerb BioTech Astragaloside IV Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Nanjing NutriHerb BioTech Recent Development
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Astragaloside IV Distributors List
Table 161. Astragaloside IV Customers List
Table 162. Astragaloside IV Market Trends
Table 163. Astragaloside IV Market Drivers
Table 164. Astragaloside IV Market Challenges
Table 165. Astragaloside IV Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Astragaloside IV Product Picture
Figure 2. Global Astragaloside IV Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Astragaloside IV Market Share by Type in 2023 & 2030
Figure 4. 0.1 Product Picture
Figure 5. 0.98 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Astragaloside IV Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Astragaloside IV Market Share by Application in 2023 & 2030
Figure 9. Food Industry
Figure 10. Pharmaceuticals Industry
Figure 11. Others
Figure 12. Astragaloside IV Report Years Considered
Figure 13. Global Astragaloside IV Capacity, Production and Utilization (2019-2030) & (MT)
Figure 14. Global Astragaloside IV Production Market Share by Region in Percentage: 2023 Versus 2030
Figure 15. Global Astragaloside IV Production Market Share by Region (2019-2030)
Figure 16. Astragaloside IV Production Growth Rate in North America (2019-2030) & (MT)
Figure 17. Astragaloside IV Production Growth Rate in Europe (2019-2030) & (MT)
Figure 18. Astragaloside IV Production Growth Rate in China (2019-2030) & (MT)
Figure 19. Astragaloside IV Production Growth Rate in Japan (2019-2030) & (MT)
Figure 20. Global Astragaloside IV Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 21. Global Astragaloside IV Revenue 2019-2030 (US$ Million)
Figure 22. Global Astragaloside IV Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 23. Global Astragaloside IV Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 24. Global Astragaloside IV Revenue Market Share by Region (2019-2030)
Figure 25. Global Astragaloside IV Sales 2019-2030 ((MT)
Figure 26. Global Astragaloside IV Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (MT)
Figure 27. Global Astragaloside IV Sales Market Share by Region (2019-2030)
Figure 28. US & Canada Astragaloside IV Sales YoY (2019-2030) & (MT)
Figure 29. US & Canada Astragaloside IV Revenue YoY (2019-2030) & (US$ Million)
Figure 30. Europe Astragaloside IV Sales YoY (2019-2030) & (MT)
Figure 31. Europe Astragaloside IV Revenue YoY (2019-2030) & (US$ Million)
Figure 32. China Astragaloside IV Sales YoY (2019-2030) & (MT)
Figure 33. China Astragaloside IV Revenue YoY (2019-2030) & (US$ Million)
Figure 34. Asia (excluding China) Astragaloside IV Sales YoY (2019-2030) & (MT)
Figure 35. Asia (excluding China) Astragaloside IV Revenue YoY (2019-2030) & (US$ Million)
Figure 36. Middle East, Africa and Latin America Astragaloside IV Sales YoY (2019-2030) & (MT)
Figure 37. Middle East, Africa and Latin America Astragaloside IV Revenue YoY (2019-2030) & (US$ Million)
Figure 38. The Astragaloside IV Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 39. The Top 5 and 10 Largest Manufacturers of Astragaloside IV in the World: Market Share by Astragaloside IV Revenue in 2023
Figure 40. Global Astragaloside IV Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 41. Global Astragaloside IV Sales Market Share by Type (2019-2030)
Figure 42. Global Astragaloside IV Revenue Market Share by Type (2019-2030)
Figure 43. Global Astragaloside IV Sales Market Share by Application (2019-2030)
Figure 44. Global Astragaloside IV Revenue Market Share by Application (2019-2030)
Figure 45. US & Canada Astragaloside IV Sales Market Share by Type (2019-2030)
Figure 46. US & Canada Astragaloside IV Revenue Market Share by Type (2019-2030)
Figure 47. US & Canada Astragaloside IV Sales Market Share by Application (2019-2030)
Figure 48. US & Canada Astragaloside IV Revenue Market Share by Application (2019-2030)
Figure 49. US & Canada Astragaloside IV Revenue Share by Country (2019-2030)
Figure 50. US & Canada Astragaloside IV Sales Share by Country (2019-2030)
Figure 51. U.S. Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 52. Canada Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 53. Europe Astragaloside IV Sales Market Share by Type (2019-2030)
Figure 54. Europe Astragaloside IV Revenue Market Share by Type (2019-2030)
Figure 55. Europe Astragaloside IV Sales Market Share by Application (2019-2030)
Figure 56. Europe Astragaloside IV Revenue Market Share by Application (2019-2030)
Figure 57. Europe Astragaloside IV Revenue Share by Country (2019-2030)
Figure 58. Europe Astragaloside IV Sales Share by Country (2019-2030)
Figure 59. Germany Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 60. France Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 61. U.K. Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 62. Italy Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 63. Russia Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 64. China Astragaloside IV Sales Market Share by Type (2019-2030)
Figure 65. China Astragaloside IV Revenue Market Share by Type (2019-2030)
Figure 66. China Astragaloside IV Sales Market Share by Application (2019-2030)
Figure 67. China Astragaloside IV Revenue Market Share by Application (2019-2030)
Figure 68. Asia Astragaloside IV Sales Market Share by Type (2019-2030)
Figure 69. Asia Astragaloside IV Revenue Market Share by Type (2019-2030)
Figure 70. Asia Astragaloside IV Sales Market Share by Application (2019-2030)
Figure 71. Asia Astragaloside IV Revenue Market Share by Application (2019-2030)
Figure 72. Asia Astragaloside IV Revenue Share by Region (2019-2030)
Figure 73. Asia Astragaloside IV Sales Share by Region (2019-2030)
Figure 74. Japan Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 75. South Korea Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 76. China Taiwan Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 77. Southeast Asia Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 78. India Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Astragaloside IV Sales Market Share by Type (2019-2030)
Figure 80. Middle East, Africa and Latin America Astragaloside IV Revenue Market Share by Type (2019-2030)
Figure 81. Middle East, Africa and Latin America Astragaloside IV Sales Market Share by Application (2019-2030)
Figure 82. Middle East, Africa and Latin America Astragaloside IV Revenue Market Share by Application (2019-2030)
Figure 83. Middle East, Africa and Latin America Astragaloside IV Revenue Share by Country (2019-2030)
Figure 84. Middle East, Africa and Latin America Astragaloside IV Sales Share by Country (2019-2030)
Figure 85. Brazil Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 86. Mexico Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 87. Turkey Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 88. Israel Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 89. GCC Countries Astragaloside IV Revenue (2019-2030) & (US$ Million)
Figure 90. Astragaloside IV Value Chain
Figure 91. Astragaloside IV Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 3.3% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Astragaloside IV market size from 2024 to 2030?
What was the global market size of Astragaloside IV in 2030?
Which companies rank high in the global Astragaloside IV market?
What was the global market size of Astragaloside IV in 2024?
Related Reports
Astragaloside IV- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Astragaloside IV was estimated to be worth US$ 78.46 million in 2025 and is projected to reach US$ 98 million, growing at a CAGR of 3.3% from 2026 to 2032.
Published Date: 2026-07-09
Pages: 127
USD 3950.00
(Single User License)
Global Astragaloside IV Market Research Report 2026
The global Astragaloside IV market was valued at US$ 78.46 million in 2025 and is anticipated to reach US$ 98 million by 2032, at a CAGR of 3.3% from 2026 to 2032.
Published Date: 2026-04-25
Pages: 128
USD 2900.00
(Single User License)
Global Astragaloside IV Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Astragaloside IV market is projected to grow from US$ 76.2 million in 2024 to US$ 95.3 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 131
USD 4900.00
(Single User License)
Global Astragaloside IV Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Astragaloside IV market size was US$ 76.2 million in 2024 and is forecast to a readjusted size of US$ 95.3 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 76
USD 4250.00
(Single User License)
Global Astragaloside IV Market Research Report 2025
The global market for Astragaloside IV was valued at US$ 76.2 million in the year 2024 and is projected to reach a revised size of US$ 95.3 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published Date: 2025-02-21
Pages: 89
USD 2900.00
(Single User License)
Astragaloside IV- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Astragaloside IV was estimated to be worth US$ 76.2 million in 2024 and is forecast to a readjusted size of US$ 95.3 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 94
USD 3950.00
(Single User License)
Global Astragaloside IV Market Research Report 2024
Astragaloside IV extract from astragalus Root.
Published Date: 2024-01-10
Pages: 88
USD 2900.00
(Single User License)
Astragaloside IV- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Astragaloside IV was estimated to be worth US$ 78.46 million in 2025 and is projected to reach US$ 98 million, growing at a CAGR of 3.3% from 2026 to 2032.
Published: 2026-07-09
Pages: 127
USD 3950.00 (Single User License)Global Astragaloside IV Market Research Report 2026
The global Astragaloside IV market was valued at US$ 78.46 million in 2025 and is anticipated to reach US$ 98 million by 2032, at a CAGR of 3.3% from 2026 to 2032.
Published: 2026-04-25
Pages: 128
USD 2900.00 (Single User License)Global Astragaloside IV Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Astragaloside IV market is projected to grow from US$ 76.2 million in 2024 to US$ 95.3 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 131
USD 4900.00 (Single User License)Global Astragaloside IV Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Astragaloside IV market size was US$ 76.2 million in 2024 and is forecast to a readjusted size of US$ 95.3 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 76
USD 4250.00 (Single User License)Global Astragaloside IV Market Research Report 2025
The global market for Astragaloside IV was valued at US$ 76.2 million in the year 2024 and is projected to reach a revised size of US$ 95.3 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published: 2025-02-21
Pages: 89
USD 2900.00 (Single User License)Astragaloside IV- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Astragaloside IV was estimated to be worth US$ 76.2 million in 2024 and is forecast to a readjusted size of US$ 95.3 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 94
USD 3950.00 (Single User License)Global Astragaloside IV Market Research Report 2024
Astragaloside IV extract from astragalus Root.
Published: 2024-01-10
Pages: 88
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now